Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2025)

Rapid Micro Biosystems' Gross Margin history spans 6 years, with the latest figure at 70.55% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 684.0% to 70.55% in Q4 2025 year-over-year; TTM through Dec 2025 was 64.03%, a 1132.0% increase, with the full-year FY2025 number at 64.03%, up 1132.0% from a year prior.
  • Gross Margin hit 70.55% in Q4 2025 for Rapid Micro Biosystems, up from 63.06% in the prior quarter.
  • Over the last five years, Gross Margin for RPID hit a ceiling of 70.55% in Q4 2025 and a floor of 5.72% in Q4 2022.
  • Historically, Gross Margin has averaged 43.16% across 5 years, with a median of 47.13% in 2021.
  • Biggest five-year swings in Gross Margin: crashed -3933bps in 2022 and later skyrocketed 4440bps in 2023.
  • Tracing RPID's Gross Margin over 5 years: stood at 35.58% in 2021, then tumbled by -84bps to 5.72% in 2022, then soared by 777bps to 50.12% in 2023, then grew by 27bps to 63.71% in 2024, then rose by 11bps to 70.55% in 2025.
  • Business Quant data shows Gross Margin for RPID at 70.55% in Q4 2025, 63.06% in Q3 2025, and 57.12% in Q2 2025.